LBA51 EMPOWER-Lung 3: Cemiplimab in combination with platinum doublet chemotherapy for first-line (1L) treatment of advanced non-small cell lung cancer (NSCLC)
| Autor: | Gogishvili, M., Melkadze, T., Makharadze, T., Giorgadze, D., Dvorkin, M., Penkov, K.D., Laktionov, K., Nemsadze, G., Nechaeva, M., Rozhkova, I., Kalinka, E., Gessner, C., Moreno-Jaime, B., Passalacqua, R., Li, S., McGuire, K., Quek, R.G.W., Gullo, G., Rietschel, P. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S1328-S1328 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|